Monday, June 15, 2026

Why Anthropic Calls for a Global Pause on AI Development: The Risks of Recursive Self-Improvement

Anthropic calls for a global pause on advanced AI development to address risks of autonomous self-improvement amid competitive pressures.

NVIDIA’s Jensen Huang Announces AI Collaboration with Naver: What It Means for the Future of Robotics and Cloud

NVIDIA CEO Jensen Huang announces collaboration with Naver on AI models, cloud computing, and robotics to enhance technology development.

BIO USA 2025: Korea’s Pavilion Grows, Deals Multiply, and New Biotech Faces Emerge

BIO USA 2025 showcased South Korea's biotech presence, with significant participation from firms like Samsung Biologics and Lotte Biologics.

Tag: DM5167

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.